It was believed that the prevalence of two or more disorders would be higher among participants but this was not the case.
Talið var að fleiri þátttakendur myndu vera yfir klínískum mörkum í tveimur eða fleiri kvörðum vegna algengi þess í erlendum rannsóknum.